Some of these mutations are pathogenic, causing alterations in tau isoform production and microtubule dynamics to potentiate tau aggregate formation, as seen in FTDP-17, CBD, and PSP [2]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.